Guardian Bio
PrivateLast Round
Seed Round
Mar 3, 2026
Total Funding Raised
$500,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Guardian Bio is a biotechnology company developing a dendritic cell-based platform for cancer therapy to drive anti-tumor activity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guardian Bio Comparables
Compare Guardian Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Diakonos Oncology | 84% | |
| CellxLife | 81% | |
| Corner Therapeutics | 78% |
Guardian Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 3, 2026 | ||||
| Series A | Aug 12, 2024 | ||||
| Seed | Jan 9, 2023 | ||||
| Accelerator | Aug 1, 2022 |
Guardian Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Creative Destruction Lab | Accelerator |
| Y Combinator | Accelerator |
| Fundament | Accelerator |
| Brazen Capital | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 455% MoM.
- May 20, 2026
Monthly visitors increased 207% MoM, reaching 709.
Guardian Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Guardian Bio's valuation, stock price, and market status.
Is Guardian Bio a public or private company?
Guardian Bio is a private company.
What is the current stock price of Guardian Bio?
Guardian Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Guardian Bio worth (valuation)?
Valuation information for Guardian Bio is not publicly available.
Can I buy Guardian Bio stock?
Guardian Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Guardian Bio's last funding round?
Guardian Bio's most recent funding round was Seed Round on March 3, 2026.
Who are the main investors in Guardian Bio?
Key investors in Guardian Bio include Y Combinator.
Will Guardian Bio IPO soon?
No public IPO plans have been announced for Guardian Bio.
How can I track Guardian Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Guardian Bio's secondary market activity and sign up for updates.